A Real-World Study to End Tyrosine Kinase Inhibitor in Chronic Myeloid Leukaemia (EnTIC) in Malaysia: One Year Follow-up of Multicenter Study in Malaysia

Autor: Chong, SiewLian *, Ong, Tee Chuan *, Asnawi, Wirda *, Wong, Tien Gen *, Ahmad Zakiyy, Mohamed *, Tham, Yea Bing *, Ahmad Shuyuti, Nur Aini Syakirah *, Binti Syed Abd Kadir, Sharifah Shahnaz *, Tan, Jerome *, Ho, Kim Wah *, Lau, Ngee Siang *, Yee Yee, Yap *, Selvaratnam, Veena *, Tan, Sen Mui *, Goh, Ai Sim *, Teoh, Ching Soon *, Keat, Sui, Lim, Soo Min *, Sharif, Azizan *, Boo, Yang Liang, Liam, Christopher, Kori, Ahlam Naila *, Toh, See Guan *, Gan, Ee Leng *, Ng, Si Yuan *, Hon, Siong Leng *, Tan, Jenq Tzong *
Zdroj: In Blood 15 November 2022 140 Supplement 1:12213-12214
Databáze: ScienceDirect